We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMC icon
251
Omnicom Group
OMC
$23.5B
$11.7M 0.07%
113,180
+37,962
+50% +$3.65M
AGIO icon
252
Agios Pharmaceuticals
AGIO
$2.08B
$11.6M 0.07%
261,505
-61,377
-19% -$2.79M
IDXX icon
253
Idexx Laboratories
IDXX
$44.9B
$11.6M 0.07%
22,934
+4,850
+27% +$2.36M
T icon
254
AT&T
T
$164B
$11.5M 0.07%
521,549
+17,857
+4% +$355K
AJG icon
255
Arthur J. Gallagher & Co
AJG
$69.1B
$11.5M 0.07%
16,090
+1,091
+7% +$308K
TMUS icon
256
T-Mobile US
TMUS
$195B
$11.5M 0.07%
55,512
+2,450
+5% +$469K
PFE icon
257
Pfizer
PFE
$143B
$11.4M 0.07%
392,294
-383,303
-49% -$11.2M
BMI icon
258
Badger Meter
BMI
$3.87B
$11.3M 0.07%
51,924
+11,026
+27% +$2.21M
VMC icon
259
Vulcan Materials
VMC
$36.8B
$11.2M 0.06%
9,089
-20
-0.2% -$4.97K
YPF icon
260
YPF
YPF
$19.7B
$11.2M 0.06%
+495,600
New +$10.6M
C icon
261
Citigroup
C
$213B
$11.2M 0.06%
178,203
+403
+0.2% +$24.9K
BLD
262
DELISTED
TopBuild
BLD
$10.9M 0.06%
26,904
-15,283
-36% -$6.16M
ITW icon
263
Illinois Tool Works
ITW
$84.1B
$10.9M 0.06%
41,671
+2,108
+5% +$519K
MTD icon
264
Mettler-Toledo International
MTD
$28.1B
$10.9M 0.06%
7,249
+4,400
+154% +$6.18M
ONTO icon
265
Onto Innovation
ONTO
$10.9B
$10.8M 0.06%
+52,075
New +$10.5M
BIO icon
266
Bio-Rad Laboratories Class A
BIO
$8.76B
$10.5M 0.06%
31,527
+8,153
+35% +$2.59M
AMT icon
267
American Tower
AMT
$83.5B
$10.5M 0.06%
45,181
+1,269
+3% +$281K
HR icon
268
Healthcare Realty
HR
$7.56B
$10.4M 0.06%
573,906
+33,142
+6% +$588K
LEA icon
269
Lear
LEA
$7.39B
$10.3M 0.06%
94,777
-21,484
-18% -$2.44M
GEN icon
270
Gen Digital
GEN
$16.5B
$10.3M 0.06%
133,072
+3,958
+3% +$102K
SLB icon
271
SLB Ltd
SLB
$72.7B
$10.1M 0.06%
240,403
-538,699
-69% -$24M
HALO icon
272
Halozyme
HALO
$9.88B
$9.99M 0.06%
174,578
+73,765
+73% +$4.23M
SFM icon
273
Sprouts Farmers Market
SFM
$7.44B
$9.99M 0.06%
90,479
+83,135
+1,132% +$7.93M
CHE icon
274
Chemed
CHE
$7.16B
$9.62M 0.06%
16,011
+6,290
+65% +$3.57M
CYTK icon
275
Cytokinetics
CYTK
$10.6B
$9.46M 0.05%
179,200
– –
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.